Biofrontera (BFRI) EBIT Margin Growth (1y) (2021 - 2025)
Biofrontera (BFRI) EBIT Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -2,102.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1,962.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -12,673.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,276.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -583.00 |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 4,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,029.00 |
| Sep 30, 2025 | -3,480.00 |
| Jun 30, 2025 | 844.00 |
| Mar 31, 2025 | 1,615.00 |
| Dec 31, 2024 | 2,284.00 |
| Sep 30, 2024 | -310.00 |
| Jun 30, 2024 | 8,406.00 |
| Mar 31, 2024 | -621.00 |
| Dec 31, 2023 | 1,854.00 |
| Sep 30, 2023 | 3,226.00 |
| Jun 30, 2023 | -938.00 |
| Mar 31, 2023 | -3,099.00 |
| Dec 31, 2022 | -3,428.00 |
| Sep 30, 2022 | 28,740.00 |
| Jun 30, 2022 | -7,640.00 |
| Mar 31, 2022 | 4,188.00 |
| Dec 31, 2021 | -1,854.00 |
| Sep 30, 2021 | -29,952.00 |